TV News LIES

The United States on Thursday hit a new record for a single-day increase in coronavirus infections with nearly 90,000 new cases reported, according to data collected from Johns Hopkins University.

On Thursday, the U.S. had 88,521 new coronavirus cases, an increase of 9,540 from the number of new infections recorded Wednesday.

The Johns Hopkins University data shows that since the pandemic first hit the U.S., there have been a total of 8,948,099 confirmed COVID-19 cases in the country and at least 228,696 deaths.

More...

A third of U.S. states are reporting higher coronavirus case counts than they've ever had before.

A USA TODAY analysis of Johns Hopkins data shows 16 states set records for new cases in a week. But nearly all states are surging: 41 states had worse weeks than they did a week earlier. And an analysis of COVID Tracking Project data shows that in 36 states, a higher rate of people were testing positive than in the week before.

While the data continues to show the virus' reach is not letting up, the head of the World Health Organization said achieving herd immunity by allowing the virus to spread is "scientifically and ethically problematic."

"Herd immunity is achieved by protecting people from a virus, not by exposing them to it," WHO Director-General Tedros Ghebreyesus said Monday, adding that the strategy relies on vaccination.

More...

Nick  Luna, one of President Trump’s personal assistants, is the latest White house aide to receive a positive coronavirus diagnosis, Bloomberg reports.

The new outlet noted that Luna works closely with Trump and serves as one of the president’s “body men.”

The Hill has reached out to the White House for comment on the aide’s reported diagnosis, which comes several days after Trump and first lady Melania Trump were confirmed to have tested positive for coronavirus.

After the Food and Drug Administration offered shaky data to justify its approval of blood plasma to treat COVID-19, some scientists are worried the agency could bow to pressure to approve a coronavirus vaccine before it's fully tested.

On Sunday, President Donald Trump announced that the FDA had issued an Emergency Use Authorization for blood plasma. The president, the Health and Human Services secretary and the head of the FDA all said the treatment reduced deaths in COVID-19 patients by 35%.

It did not, and scientists immediately questioned the FDA’s claims about the data.

“You saw FDA be bullied by the president of the United States into approving something that they didn’t want to approve earlier, because he wanted them to do that,” said Dr. Paul Offit, director of the Vaccine Education Center at Children's Hospital in Philadelphia, in an online interview Monday with the editor of the Journal of the American Medical Association.

More...

 

 

President Donald Trump is eyeing another unproven coronavirus "cure," at the recommendation of Housing and Urban Development Secretary Ben Carson, Axios reported Sunday.

Oleandrin — a botanical extract from the oleander plant — was suggested to the president by Carson in a meeting in the Oval Office in July, according to the Axios report.

MyPillow's founder and CEO, Mike Lindell, who's known to be well-connected with the president, also is said to have expressed support for the experimental extract. Lindell has a financial stake in the company developing the oleandrin product, Phoenix Biotechnology.

TVNL Comment:  Maniacs are charge of the asylum.  Not to believe.

More...

The United States is tying payments for COVID-19 vaccines to timing milestones for production and approval, according to public documents and a Trump administration official, putting pressure on drugmakers including Moderna Inc (MRNA.O) to meet ambitious targets.

In a deal with Moderna announced this week, federal agencies negotiated a sliding scale of payments. The Cambridge, Massachusetts, biotech’s $1.5-billion deal pays out in full if its vaccine receives regulatory clearance by January 31, 2021, according to filings. It receives $1.2 billion, if it falls short of that timing goal.

Moderna also receives $600 million when it can demonstrate it has built out industrial-scale manufacturing capabilities for its vaccine, even if that happens before the drug is authorized by regulators, the filings show.

TVNL Comment:  Money talks.  Billions of dollars talk very loudly.  Be ready for an untested, very possibly unsafe, and surely premature vaccine.

More...